| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ... The American Journal of Human Genetics 72 (5), 1117-1130, 2003 | 3895 | 2003 |
| Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype SR Lakhani, JS Reis-Filho, L Fulford, F Penault-Llorca, M van der Vijver, ... Clinical cancer research 11 (14), 5175-5180, 2005 | 738 | 2005 |
| Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts HFA Vasen, I Blanco, K Aktan-Collan, JP Gopie, A Alonso, S Aretz, ... Gut 62 (6), 812-823, 2013 | 641 | 2013 |
| Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service DG Evans, E Howard, C Giblin, T Clancy, H Spencer, SM Huson, F Lalloo American journal of medical genetics Part A 152 (2), 327-332, 2010 | 600 | 2010 |
| The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions AC Antoniou, AP Cunningham, J Peto, DG Evans, F Lalloo, SA Narod, ... British journal of cancer 98 (8), 1457-1466, 2008 | 482 | 2008 |
| Germline mutations in RAD51D confer susceptibility to ovarian cancer C Loveday, C Turnbull, E Ramsay, D Hughes, E Ruark, JR Frankum, ... Nature genetics 43 (9), 879-882, 2011 | 451 | 2011 |
| Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD CJ Ricketts, JR Forman, E Rattenberry, N Bradshaw, F Lalloo, L Izatt, ... Human mutation 31 (1), 41-51, 2010 | 343 | 2010 |
| Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme E Amir, DG Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, ... Journal of medical genetics 40 (11), 807-814, 2003 | 325 | 2003 |
| Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations E Barrow, L Robinson, W Alduaij, A Shenton, T Clancy, F Lalloo, J Hill, ... Clinical genetics 75 (2), 141-149, 2009 | 311 | 2009 |
| Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 66 (3), 464-472, 2017 | 296 | 2017 |
| Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS Genet 9 (3), e1003212, 2013 | 278 | 2013 |
| A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO DGR Evans, DM Eccles, N Rahman, K Young, M Bulman, E Amir, ... Journal of medical genetics 41 (6), 474-480, 2004 | 268 | 2004 |
| Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 67 (7), 1306-1316, 2018 | 232 | 2018 |
| Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations A Moran, C O’hara, S Khan, L Shack, E Woodward, ER Maher, F Lalloo, ... Familial cancer 11 (2), 235-242, 2012 | 230 | 2012 |
| Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction AC Antoniou, J Beesley, L McGuffog, OM Sinilnikova, S Healey, ... Cancer research 70 (23), 9742-9754, 2010 | 217 | 2010 |
| Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer E Ruark, K Snape, P Humburg, C Loveday, I Bajrami, R Brough, ... Nature 493 (7432), 406-410, 2013 | 216 | 2013 |
| Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer … DG Evans, A Shenton, E Woodward, F Lalloo, A Howell, ER Maher BMC cancer 8 (1), 1-9, 2008 | 213 | 2008 |
| Familial breast cancer F Lalloo, DG Evans Clinical genetics 82 (2), 105-114, 2012 | 211 | 2012 |
| Prediction of pathogenic mutations in patients with early-onset breast cancer by family history F Lalloo, J Varley, D Ellis, A Moran, L O'Dair, P Pharoah, DGR Evans, ... The Lancet 361 (9363), 1101-1102, 2003 | 195 | 2003 |
| Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study SL Neuhausen, AK Godwin, R Gershoni-Baruch, E Schubert, J Garber, ... The American Journal of Human Genetics 62 (6), 1381-1388, 1998 | 186 | 1998 |
Evans DG*, Evans G*University of ManchesterVerified email at mft.nhs.uk
